NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Disease will provide up to $26 million to cooperative research partnerships that address biodefense and emerging infectious disease issues.
The program aims to develop diagnostics, vaccines, therapeutics, and immunotherapeutics specific to Category A, B, and C pathogens or toxins.
The $26 million will fund between 15 and 20 awards, and the size and duration of these awards will vary.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.